The Price of Forever — Episode 1: Drink Deep (Young Blood Transfusions)
0:0013:23
The Price of Forever — Episode 1: Drink Deep (Young Blood Transfusions)
A California startup was charging $8,000 to infuse you with a teenager’s plasma. They called it a clinical trial. The FDA disagreed. Episode 1 profiles young-blood transfusions: what the science actually shows (mostly rodents, mostly murky), what Bryan Johnson found when he tried it with his own family (nothing), the real documented risks, and why the FDA warning from 2019 still stands.
2026. 6. 10. · 20:43
The Price of Forever — Episode 1: Drink Deep
About this episode
A startup in California was charging $8,000 to infuse you with a teenager's blood plasma. They called it a clinical trial. No control group, no blinding, no randomization. The FDA shut them down in 2019. They reopened.
In this episode, Dr. Vale and Dr. Chen profile young-blood and plasma transfusions as an anti-aging intervention — one of the most literal, expensive, and medically murky practices at the extreme edge of longevity science.
Covered in this episode:
- What young-blood transfusions actually are, and the 1950s parabiosis experiments that spawned the idea
- What the peer-reviewed science actually shows (mostly rodents, mostly indirect markers, with at least one study suggesting saline works just as well)
- Bryan Johnson's 2023 multigenerational plasma exchange — and his admission of "no benefits"
- Pricing: from Ambrosia's $8,000–$12,000 to current offshore clinic rates
- The 2019 FDA warning (updated December 2024), still active
- Documented real risks: TRALI, allergic reactions, circulatory overload, and a JAMA Internal Medicine finding that blood from donors under 20 was associated with modestly higher recipient mortality
- How these clinics stay in business: clinical trial grey zones, compounding pharmacies, and medical tourism
This is not medical advice. This is not an endorsement of any practice described. This program treats extreme anti-aging practices as cautionary spectacle, not recommendations.
Sources
- FDA: Important information about young donor plasma infusions offered for profit (Feb 2019, updated Dec 2024)
- Young blood transfusion — Wikipedia (comprehensive reference with primary citations)
- Bryan Johnson admits "no benefits" after plasma exchange — Fortune, July 2023
- Ambrosia: The startup harvesting the blood of the young — The Guardian, Aug 2017
- Conboy et al. 2005, "Rejuvenation of aged progenitor cells by exposure to a young systemic environment" — Nature
- Mehdipour et al. 2020, "Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin" — Aging
- FDA issues warning about young-blood transfusions — Scientific American, Feb 2019
The Price of Forever is a chronicle of what the ultra-wealthy and hardcore biohackers actually do to try to cheat death — and what the science actually says about it. Morbid spectacle. Hard medical reality check. Never credulous.
이 콘텐츠를 둘러싼 관점이나 맥락을 계속 보강해 보세요.